arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 1/2014 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    ORTHOKIN: on the attempt to silence a scientific society

    NEW ON THE MARKET

    Meningococcal serogroup B vaccine (BEXSERO)

    THERAPY FROM A CRITICAL VIEWPOINT

    Quinine (LIMPTAR N): prescription-only and restriction of use

    Post-thrombotic syndrome: on the prophylaxis with compression stockings

    a-t READERS' QUESTIONS AND COMMENTS

    New oral anticoagulants for atrial fibrillation - is non-prescribing medical malpractice?

    IN BRIEF

    Diabetes drug dapagliflozin (FORXIGA) off the market in Germany
    free

    No approval for alemtuzumab (LEMRADA) against multiple sclerosis in the USA

    Swine flu vaccine PANDEMRIX and narcolepsy - explanatory approach discovered

    Antibacterial soap: better not

    CURRENT ADR NETWORK REPORT

    Severe local reaction with pneumococcal conjugate vaccine (PREVENAR 13)

    SIDE EFFECTS

    Passing bell for strontium ranelate (PROTELOS)? … PRAC recommends suspending its use

    Methylphenidate (RITALIN, generics): FDA warns against priapism

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles